Patent details

EP3028702 Title: METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS

Basic Information

Publication number:
EP3028702
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP161533351
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS
French Title of Invention:
PROCÉDÉS DE TRAITEMENT UTILISANT DES INHIBITEURS BCL-2 SÉLECTIFS
German Title of Invention:
BEHANDLUNGSVERFAHREN UNTER VERWENDUNG SELEKTIVER BCL-2-INHIBITOREN
SPC Number:

Dates

Filing date:
22/11/2011
Grant date:
12/09/2018
EP Publication Date:
08/06/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/09/2018
EP B1 Publication Date:
12/09/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/11/2018
Expiration date:
22/11/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/09/2018
 
 

Name:
AbbVie Ireland Unlimited Company
Address:
70 Sir John Rogerson's Quay, Dublin 2, Ireland (IE)

Inventor

1

Name:
ELMORE, Steven
Address:
United States (US)

2

Name:
SOUERS, Andrew
Address:
United States (US)

3

Name:
GHAYUR, Tariq
Address:
United States (US)

4

Name:
WANG, Li Chun
Address:
United States (US)

5

Name:
PERPER, Stuart J.
Address:
United States (US)

Priority

Priority Number:
416689 P
Priority Date:
23/11/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/496; A61P 37/00;

Publication

European Patent Bulletin

Issue number:
201837
Publication date:
12/09/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/03/2019 Outgoing Correspondence 1